GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (LTS:0OPB) » Definitions » Tax Expense

McKesson Europe AG (LTS:0OPB) Tax Expense : €14 Mil (TTM As of Mar. 2022)


View and export this data going back to 2010. Start your Free Trial

What is McKesson Europe AG Tax Expense?

McKesson Europe AG's tax expense for the six months ended in Mar. 2022 was €14 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2022 was €14 Mil.


McKesson Europe AG Tax Expense Historical Data

The historical data trend for McKesson Europe AG's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG Tax Expense Chart

McKesson Europe AG Annual Data
Trend Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.90 44.30 36.60 14.90 14.30

McKesson Europe AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.90 44.30 36.60 14.90 14.30

McKesson Europe AG Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Tax Expense for the trailing twelve months (TTM) ended in Mar. 2022 was €14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


McKesson Europe AG  (LTS:0OPB) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


McKesson Europe AG Tax Expense Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


McKesson Europe AG (LTS:0OPB) Business Description

Traded in Other Exchanges
N/A
Address
Stockholmer Platz 1, Stuttgart, BW, DEU, 70137
McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (LTS:0OPB) Headlines

No Headlines